Showing results (31-40 of 340) with videos related to
Sort By:
Pageof 34
Plos One|September 21, 2011
A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timelinessGrigory Sidorenkov, Flora M Haaijer-Ruskamp, Dick de Zeeuw, et al.Journal of the American Society of Nephrology : JASN|February 15, 2008
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartanLiffert Vogt, Femke Waanders, Frans Boomsma, et al.Cardiovascular Drugs and Therapy|May 27, 2003
Specific drug delivery to the kidneyMarijke Haas, Frits Moolenaar, Dirk K F Meijer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2008
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patientsLiffert Vogt, Dick de Zeeuw, Arend Jan J Woittiez, et al.Journal of the American Society of Nephrology : JASN|March 7, 2000
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosisFrits H Wapstra, Gerjan Navis, Paul E DE Jong, et al.Journal of the American Society of Nephrology : JASN|September 27, 2000
Renin inhibition improves pressure natriuresis in essential hypertensionPieter VAN Paassen, Dick DE Zeeuw, Paul E DE Jong, et al.European Journal of Clinical Pharmacology|January 4, 2006
Physicians' attitudes towards treatment guidelines: differences between teaching and nonteaching hospitalsJacoba P Greving, Petra Denig, Dick de Zeeuw, et al.Heart Failure Monitor|March 14, 2003
Renal function as a predictor of prognosis in chronic heart failureHans Hillege, Wiek Van Gilst, Dick de Zeeuw, et al.Journal of Hypertension|February 7, 2007
Claims in advertisements for antihypertensive drugs in a Dutch medical journalJacoba P Greving, Petra Denig, Dick de Zeeuw, et al.Plos One|October 1, 2014
The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholdersBauke Schievink, Hiddo Lambers Heerspink, Hubert Leufkens, et al.Pageof 34